International Clinical Trial: Evaluation of Safety and Effectiveness of the EMBLOK EPS Compared With No Cerebral Embolic Protection During TAVR

Geneva, Aug. 29 -- International Clinical Trials Registry received information related to the study (NCT07129421) titled 'Evaluation of Safety and Effectiveness of the EMBLOK EPS Compared With No Cerebral Embolic Protection During TAVR' on Aug. 4.

Study Type: Interventional

Study Design: Allocation: Randomized. Intervention model: Parallel Assignment. Primary purpose: Prevention. Masking: Single (Outcomes Assessor).

Primary Sponsor: Emblok, Inc.

Condition: AORTIC VALVE DISEASES Aortic Valve Stenosis and/or Insufficiency Aortic Valve Regurgitation Aortic Valve Replacement

Intervention: Device: EMBLOK™ Embolic Protection System ("EMBLOK EPS")

Recruitment Status: Not recruiting

Phase: N/A

Date of First Enrollment: October ...